SS Innovations International (SSII) Assets (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.99% |
| Dec 31, 2025 | 6.68% |
| Sep 30, 2025 | -0.57% |
| Jun 30, 2025 | 10.28% |
| Mar 31, 2025 | 49.71% |
| Dec 31, 2024 | 8.62% |
| Sep 30, 2024 | 9.40% |
| Jun 30, 2024 | 1.32% |
| Mar 31, 2024 | 11.69% |
| Dec 31, 2023 | 11.94% |
| Sep 30, 2023 | 126.51% |
| Jun 30, 2023 | 127.39% |
| Mar 31, 2023 | -21.69% |
| Dec 31, 2022 | 323.35% |
| Sep 30, 2022 | 490.29% |
| Jun 30, 2022 | -23.97% |
| Mar 31, 2022 | -14.28% |
| Dec 31, 2021 | 28.17% |
| Sep 30, 2021 | -24.01% |
| Jun 30, 2021 | -5.70% |
| Mar 31, 2021 | 46.80% |
| Dec 31, 2020 | 515.30% |
| Sep 30, 2020 | -21.43% |
| Jun 30, 2020 | -17.62% |
| Mar 31, 2020 | -39.78% |
| Dec 31, 2019 | -29.47% |
| Sep 30, 2019 | -9.33% |
| Jun 30, 2019 | 25.80% |
| Mar 31, 2019 | 13.27% |
| Dec 31, 2018 | -32.80% |
| Sep 30, 2018 | -24.01% |
| Jun 30, 2018 | -30.62% |
| Mar 31, 2018 | -19.51% |
| Dec 31, 2017 | -10.48% |
| Sep 30, 2017 | 219.91% |